[1] |
LU Jing, CAI Lei, TONG Fei, YU Changhui, FU Shunjun, PAN Mingxin.
One Case of Ischemic Colitis Caused by Compound Polyethylene Glycol Electrolyte Powder
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 699-701.
|
[2] |
LI Can, LIU Lehuan, CHEN Xia, QU Jianbo.
Pharmacy of Chinese Medicine Compound Preparations Based on Human Experiences
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 564-569.
|
[3] |
ZHENG Changhui, MA Lina, HE Ting, GU Yuanyuan, ZHAO Wei, WANG Hongbin, NIU Yuanfei, FU Yao, CHEN Yanjun, CAO Junling.
Quality Evaluation and Control of Bupleuri Radix Decoction Pieces Based on ‘Shape-Chemistry-Biology' Sequential Detection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 197-205.
|
[4] |
JIA Juanjuan, SUN Jiabei, ZHANG Wenzai, SUN Deyang, SHI Yaqin, HUANG Haiwei.
Biological Distribution of 99mTc-DMSA Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 47-52.
|
[5] |
SHAO Bo, ZHONG Lumiao, CHENG Yuzhu, DENG Hua, ZHU Lan.
Risks to Safety of Yinhuang Oral Preparation
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 84-87.
|
[6] |
GUO Shushu, JIANG Haiyan, FAN Xiaoyu, LI Wanfang, BAO Jie, MA Enlong, JIN Hongtao.
Rationality of compound drug components against hypertension
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 973-977.
|
[7] |
SUN Siman, JIANG Haiyan, FAN Xiaoyu, LI Wanfang, BAO Jie, WANG Chuan, JIN Hongtao.
Research progress in anti-AIDS compound preparations
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 978-984.
|
[8] |
ZHOU Simin, LIN Jianguo, WANG Qingqing, YAO Kuiwu.
Effect of Erzhu Tianma granules on model rats with prehypertension phlegm-dampness syndrome
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 998-1007.
|
[9] |
LU Zhenkai, YANG Dingquan, XIE Zhennian, WANG Lianxin, LI Yuanyuan, WANG Zhifei, CUI Xin, XIE Yanming.
Interpretation and insights from the “Guidelines for Pharmacovigilance of Topical Traditional Chinese Medicines in Clinical Applications”
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1029-1033.
|
[10] |
SUN Li, XIE Bin, XU Yanqin.
Research progress of sustained and controlled release preparations of Chinese medicine
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 949-954.
|
[11] |
SUN Yue, HU Xinyue, LI Jing, ZHANG Wei, DING Xiaoli, ZHANG Hui, LIANG Chenggang.
Quality evaluation of desmopressin tablets and injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 632-637.
|
[12] |
DING Xiaoli, HU Xinyue, WANG Xuelei, SUN Yue, LI Jing, ZHANG Hui, Liang Chenggang, WANG Yan.
Quality evaluation of insulin glargine injections
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 644-650.
|
[13] |
YU Xin, GONG Leilei, YAO Weijie, YUAN Sisi, FENG Xin.
Chinese patent medicines for recurrent spontaneous abortion: a scoping review of clinical evidence
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 361-365.
|
[14] |
HUANG Shuguang, ZHANG Xuenong.
Pharmacodynamics of peptide drug BR0336 in a mouse model of T2DM combined with NASH
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 415-421.
|
[15] |
YAO Rongmei, MAO Xin, XU Yingli, ZHANG Zhibin, GAO Yingjie, BAO Lei, BAO Yanyan, MENG Fengxian, CUI Xiaolan.
Effect of Tutengcao granules on MSU-induced acute gouty arthritis in rabbits
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 263-268.
|